He Made Pfizer a Household Name. Wall Street Wants More.
With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...
After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
Pfizer Went From Covid Star to Activist Target as Stock Fell
Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its ...
Pfizer taps Vanguard veteran for board amid fight with Starboard
Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...
Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?
Will this clash between a major shareholder and management, current and former, harm the stock? Or is the situation merely an ...
What Critics of Pfizer Are Getting Wrong
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...
The Day3d
After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump
Albert Bourla, who four years ago led Pfizer through its scientific and financial triumph during the COVID-19 pandemic, is suddenly facing a new challenge from a large shareholder frustrated over ...
Guggenheim caught in Starboard-Pfizer crossfire
Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.
Tim Buckley Elected to Pfizer’s Board of Directors
Pfizer Inc. (NYSE: PFE) today announced the election of Mortimer ("Tim") J. Buckley to its Board of Directors, effective ...